Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Green Mountain Care Board recommends voluntary cost‑plus and CivicaRx options to curb prescription prices
Summary
The Green Mountain Care Board presented an Act 134 report recommending voluntary, market‑based approaches — cost‑plus purchasing, CivicaRx membership, a new drug discount card, an advisory committee and improved price transparency — and reported modeled savings from cost‑plus generics and a cautionary note on federal negotiation expansion.
The Green Mountain Care Board presented the final report required under Act 134, summarizing a year‑long analysis and proposing five practical, voluntary options to reduce prescription drug costs in Vermont.
Director Catherine O'Neil and analysts said their work combined a national landscape review with data analysis (VCURES) and dashboards. "Because generics make up most prescriptions in Vermont ... it favors cost containment strategies that are voluntary and market-based," the board said, noting that VCURES does not include rebate data and that savings estimates are based on…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
